6951:TYO
JEOL Ltd
Â¥7,701.00
arrow_downward
-1.65%(-129.00) 1D
Oct 2, 3:30:00 PM GMT+9 · JPY
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 6951...
Open
Â¥7,761
High
Â¥7,895
Low
Â¥7,683
Mkt. cap
396.85B
Avg. vol.
286.33K
Volume
343.10K
Dividend
1.71%
Quarterly dividend
Â¥33
Ex-dividend date
Sep 29, 2026
P/E ratio
25.16
52-wk high
Â¥9,255
52-wk low
Â¥4,435
EPS
Â¥306
Shares outstanding
48.31M
No. of employees
4K
Open
Â¥7,761
High
Â¥7,895
Low
Â¥7,683
Mkt. cap
396.85B
Avg. vol.
286.33K
Volume
343.10K
Dividend
1.71%
Quarterly dividend
Â¥33
Ex-dividend date
Sep 29, 2026
P/E ratio
25.16
52-wk high
Â¥9,255
52-wk low
Â¥4,435
EPS
Â¥306
Shares outstanding
48.31M
No. of employees
4K
News stories
From web sources and news partners
The Motley Fool
·
2 hours ago
History Says Coca-Cola Stock Holds Up When the S&P 500 Falls
TradingView
·
7 hours ago
Energy sector outperforms S&P 500 in Q3 as oil prices rise
Profile
JEOL, Ltd. is a major developer and manufacturer of electron microscopes and other scientific instruments, industrial equipment and medical equipment.
Its headquarters are in Tokyo, Japan, with 25 domestic and foreign subsidiaries and associated companies as of 2014. It is listed in the top ten businesses worldwide for analytical laboratory instrument manufacturing.
It has been included in the Activest Lux Nanotech Mutual Fund and the WestLB Nanotech Fund. Wikipedia
About JEOL Ltd
CEOGonemon Kurihara
Employees3.73K
FoundedMay 30, 1949
HeadquartersAkishima, Tokyo, Japan
SectorComputer hardware
Websitejeol.co.jp
Last report
Aug 14, 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
24.46B / 30.54B
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in JPY | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 41.91B | 47.74B | 49.55B | 24.46B |
Cost of goods sold | 22.09B | 24.73B | 28.81B | 12.70B |
Cost of revenue | 22.09B | 24.73B | 28.81B | 12.70B |
Research and development expenses | 2.81B | 2.65B | 2.80B | 2.59B |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 21.40B | -21.40B | 43.52B | - |
Operating expense | 13.68B | 13.55B | 16.12B | 13.73B |
Total operating expenses | 35.77B | 38.28B | 44.93B | 26.43B |
Operating income | 6.14B | 9.46B | 4.62B | -1.96B |
Other non operating income | 217.00M | 95.00M | -127.00M | 218.00M |
EBT including unusual items | 7.13B | 10.80B | 4.80B | -1.20B |
EBT excluding unusual items | 7.12B | 10.75B | 4.96B | -1.36B |
Income tax expense | 1.95B | 3.16B | 192.00M | 511.00M |
Effective tax rate | 27.30% | - | 4.00% | -42.62% |
Other operating expenses | -10.52B | 32.29B | -32.29B | 11.14B |
Net income | 5.18B | 7.64B | 4.61B | -1.71B |
Net profit margin | 12.36% | - | 9.30% | -6.99% |
Earnings per share | - | - | - | - |
Interest and investment income | 91.00M | 155.00M | 120.00M | 176.00M |
Interest expense | -22.00M | -27.00M | -62.00M | -89.00M |
Net interest expenses | 69.00M | 128.00M | 58.00M | 87.00M |
Depreciation and amortization charges | - | - | 1.94B | - |
EBITDA | 7.41B | 10.76B | 6.00B | - |
Gain or loss from assets sale | - | - | - | - |